首页 | 本学科首页   官方微博 | 高级检索  
检索        


Molecular and clinical analyses of 84 patients with tuberous sclerosis complex
Authors:Chia-Cheng Hung  Yi-Ning Su  Shu-Chin Chien  Horng-Huei Liou  Chih-Chuan Chen  Pau-Chung Chen  Chia-Jung Hsieh  Chih-Ping Chen  Wang-Tso Lee  Win-Li Lin  Chien-Nan Lee
Institution:1. Institute of Biomedical Engineering, College of Medicine and College of Engineering, National Taiwan University, Taipei, Taiwan
10. Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan
2. Department of Medical Genetics, National Taiwan University Hospital, Taipei, Taiwan
3. Departments of Medical Genetics and Obstetrics and Gynecology, China Medical University Hospital, Taichung, Taiwan
4. Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan
5. Department of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan
6. Institute of Occupational Medicine and Industrial Hygiene, National Taiwan University College of Public Health, Taipei, Taiwan
7. Department of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei, Taiwan
8. Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan
9. Department of Obstetrics and Gynecology, National Taiwan University Hospital, Taipei, Taiwan
Abstract:

Background

Tuberous sclerosis complex (TSC) is an autosomal dominant disease characterized by the development of multiple hamartomas in many internal organs. Mutations in either one of 2 genes, TSC1 and TSC2, have been attributed to the development of TSC. More than two-thirds of TSC patients are sporadic cases, and a wide variety of mutations in the coding region of the TSC1 and TSC2 genes have been reported.

Methods

Mutational analysis of TSC1 and TSC2 genes was performed in 84 Taiwanese TSC families using denaturing high-performance liquid chromatography (DHPLC) and direct sequencing.

Results

Mutations were identified in a total of 64 (76 %) cases, including 9 TSC1 mutations (7 sporadic and 2 familial cases) and 55 TSC2 mutations (47 sporadic and 8 familial cases). Thirty-one of the 64 mutations found have not been described previously. The phenotype association is consistent with findings from other large studies, showing that disease resulting from mutations to TSC1 is less severe than disease due to TSC2 mutation.

Conclusion

This study provides a representative picture of the distribution of mutations of the TSC1 and TSC2 genes in clinically ascertained TSC cases in the Taiwanese population. Although nearly half of the mutations identified were novel, the kinds and distribution of mutation were not different in this population compared to that seen in larger European and American studies.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号